Is CNST undervalued or overvalued?
As of 2025-03-21, the Intrinsic Value of Constellation Pharmaceuticals Inc (CNST) is -0.00 USD. This CNST valuation is based on the model Peter Lynch Fair Value. With the current market price of 33.99 USD, the upside of Constellation Pharmaceuticals Inc is -100.01%. This means that CNST is overvalued by 100.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.00 - -0.00 | -0.00 | -100.01% |
| P/E | (63.73) - (90.86) | (79.81) | -334.8% |
| DDM - Stable | (62.85) - 891.90 | 414.52 | 1119.5% |
| DDM - Multi | (54.82) - 601.99 | (120.28) | -453.9% |
| Market Cap (mil) | 1,628.62 |
| Beta | 1.01 |
| Outstanding shares (mil) | 47.91 |
| Enterprise Value (mil) | 1,514.62 |
| Market risk premium | 4.24% |
| Cost of Equity | 5.49% |
| Cost of Debt | 5.00% |
| WACC | 4.57% |